Literature DB >> 6492255

Large surface proteins of hepatitis B virus containing the pre-s sequence.

K H Heermann, U Goldmann, W Schwartz, T Seyffarth, H Baumgarten, W H Gerlich.   

Abstract

The sequence of hepatitis B virus DNA contains an open reading frame which codes for a not-yet-identified protein of at least 389 amino acids. Only the products starting at the third (GP33/GP36) or the fourth (P24/GP27) initiation signal have been characterized as components of the viral surface antigen. We found a larger protein, P39, and its glycosylated form, GP42, in hepatitis B virus particles and viral surface antigen filaments. Immunological cross-reactions showed that P39/GP42 is partially homologous to P24/GP27 and GP33/GP36. The unique portion of its sequence bound monoclonal antibodies which had been induced by immunization with hepatitis B virus particles. Proteolytic cleavage patterns and subtype-specific size differences suggested that the sequence of P39 starts with the first initiation signal of the open reading frame. Its amino-terminal part (pre-s coded) is exposed at the viral surface and, probably, is highly immunogenic. A model is presented of how the open reading frame for the viral envelope leads to defined amounts of three different proteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6492255      PMCID: PMC254539     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Standardized detection of hepatitis B surface antigen: determination of its serum concentration in weight units per volume.

Authors:  W Gerlich; R Thomssen
Journal:  Dev Biol Stand       Date:  1975

2.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen.

Authors:  D L Peterson; I M Roberts; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

Review 4.  The genome of hepatitis B virus.

Authors:  W S Robinson
Journal:  Annu Rev Microbiol       Date:  1977       Impact factor: 15.500

5.  Hepatitis B surface antigen polypeptides: artifactual bands in sodium dodecyl sulfate-polyacrylamide gel electrophoresis caused by aggregation.

Authors:  V U Koistinen
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

6.  The labelling of galactose residues in hepatitis B surface antigen glycoprotein.

Authors:  J Skelly; C R Howard; A J Zuckerman
Journal:  J Gen Virol       Date:  1978-12       Impact factor: 3.891

7.  Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection.

Authors:  A Alberti; S Diana; G H Sculard; A L Eddleston; R Williams
Journal:  Br Med J       Date:  1978-10-14

8.  Selective detection of IgM-antibody against core antigen of the hepatitis B virus by a modified enzyme immune assay.

Authors:  W H Gerlich; W Lüer
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

9.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

10.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

View more
  250 in total

1.  The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen.

Authors:  T T Yuan; G K Sahu; W E Whitehead; R Greenberg; C Shih
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.

Authors:  I Desombere; Y Gijbels; A Verwulgen; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

3.  Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles.

Authors:  R Prange; R Nagel; R E Streeck
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  Comparison of pre-S1 and pre-S2 proteins in hepatocytes with replication by in situ hybridization assay.

Authors:  Y Y Zhang; Z Q Yu; Y K Wan; P Yan; L J Hao
Journal:  J Tongji Med Univ       Date:  1990

5.  Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins.

Authors:  R Prange; A Clemen; R E Streeck
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles.

Authors:  K Ueda; T Tsurimoto; K Matsubara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

7.  Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions.

Authors:  Stefan Seitz; Stephan Urban; Christoph Antoni; Bettina Böttcher
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

8.  Pre-structured motifs in the natively unstructured preS1 surface antigen of hepatitis B virus.

Authors:  Seung-Wook Chi; Do-Hyoung Kim; Si-Hyung Lee; Iksoo Chang; Kyou-Hoon Han
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

9.  Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis.

Authors:  V Bruss; K Vieluf
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1.

Authors:  M Seifer; D N Standring
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.